Dawson John Andrewinsider trades

In SEC Form 4 filings, Dawson John Andrew is listed as Director of PDS Biotechnology Corp (PDSB). Dawson John Andrew reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 21.

Companies and roles

Company	Role	Transactions	Last filed
PDSBPDS Biotechnology Corp	Director	1	Oct 21

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
PDSBPDS Biotechnology Corp	Oct 18	Oct 21	A · derivative	22,700	$1.13	$25,651	22,700	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.